About BioCentra Diagnostics
BioCentra Diagnostics is a Healthcare company based in Houston (United States) founded in 2008. State-of-the-art medical laboratory offering lab testing services for mens and womens wellness panels, allergy and infectious disease testing. BioCentra Diagnostics has raised $16.51 thousand across 1 funding round. BioCentra Diagnostics offers products and services including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Microbial Testing. Its competitors include TScan Therapeutics, Karius and Day Zero Diagnostics; 3 of its 3 listed competitors have raised funding.
Company details
BioCentra Diagnostics was established in 2008 in Houston, Texas, within the medical diagnostics sector. A range of laboratory testing services is offered, encompassing mens and womens wellness panels, allergy assessments, infectious disease screenings, and urinary tract infection pathogen panels. These operations are centered in the United States, supporting clinical diagnostics for various health conditions.
- Headquarters Houston, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biocentradx.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$16.51K (USD)
in 1 rounds
- Latest Funding Round$16.51K (USD), Seed
Aug 2015
Products & Services of BioCentra Diagnostics
BioCentra Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel.
Detects COVID-19 virus with same-day results for travel needs.
Assesses drug-gene interactions for personalized medication choices.
Evaluates genetic risk for dementia and Alzheimer’s disease.
Identifies viruses and bacteria in respiratory infections.
Detects bacteria and fungi in urinary tract infections.
Funding Insights of BioCentra Diagnostics
BioCentra Diagnostics has successfully raised a total of $16.51K through 1 strategic funding round. The most recent funding activity was a Seed round of $16.51 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16,510
- Total Rounds 1
- Last Round Seed — $16,510
- First Round $16,510
(Aug 2015)
All 1 funding rounds of BioCentra Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $16,510 | Seed | – | – | – |
Timeline of BioCentra Diagnostics
2 dated milestones of BioCentra Diagnostics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BioCentra Diagnostics is founded.
- Funding First funding round of $17K.
Competitors of BioCentra Diagnostics
BioCentra Diagnostics has 3 listed competitors in our database, 3 of them funded. They include TScan Therapeutics, Karius and Day Zero Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tscan.com | 1995 | Boston, United States | $158.3M | 154 | T cell-based treatments for immunological and oncological disorders are developed. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. |
Detailed competitors of BioCentra Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioCentra Diagnostics
The website of BioCentra Diagnostics (biocentradx.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 125.6% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as BioCentra Diagnostics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioCentra Diagnostics
BioCentra Diagnostics was founded in 2008 and raised its 1st funding round 7 years after it was founded.
BioCentra Diagnostics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
BioCentra Diagnostics is a funded company, having raised a total of $16.51K across 1 funding round to date. The company's 1st funding round was a Seed of $16.51K, raised on Aug 2015.
BioCentra Diagnostics was established in 2008 in Houston, Texas, within the medical diagnostics sector. A range of laboratory testing services is offered, encompassing mens and womens wellness panels, allergy assessments, infectious disease screenings, and urinary tract infection pathogen panels. These operations are centered in the United States, supporting clinical diagnostics for various health conditions.
BioCentra Diagnostics's top competitors include Day Zero Diagnostics, TScan Therapeutics and Karius.
BioCentra Diagnostics offers COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel.